Mission
TO PROVIDE GRANTS TO SECTION 501C3 ORGANIZATIONS THAT ADVANCE AND IMPROVE SCIENTIFIC RESEARCH IN IMMUNOTHERAPY AND TO ORGANIZATIONS THAT PROMOTE, ADVANCE AND IMPROVE EDUCATION AND SUPPORT CANCER PATIENTS
Public Charity
The National Immunotherapy Cancer
Based in Flemington, NJ, The National Immunotherapy Cancer operates as a Public Charity. The organization reported $390K in revenue, $100K in expenses, $1.2M in total assets for fiscal year 2024. Imperigo tracks 2 reported grant relationships connected to this organization totaling approximately $12K.
EIN: 223067246
Flemington, NJ
Latest filing: 2024
Total Revenue$390K
Total Expenses$100K
Total Assets$1.2M
Grant Records2
Funding Total$12K
Filing Years2020–2024
Sample Grants Received
MEDICAL RESEARCH
$6,000
Provides support to groups that promote, advance and improve scientific research in immunotherapy and organizations that promote, advance and improve the education and support of cancer patients.
$6,000
Showing up to 5 of 2 total records — full history available with membership.
Officers & Directors
Director
Don Griffin
Treasurer
Jeffrey A West
Director
Laura Johnson
President
Robert A Facchina
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $390K | $100K | $1.2M |
| 2023 | $151K | $98K | $1.1M |
| 2022 | $4K | $136K | $1.1M |
| 2021 | $6K | $78K | $1.4M |
| 2020 | $14K | $1.0M | $1.6M |
Between 2020 and 2024, reported annual revenue grew from $14K to $390K (+2693%), with total assets most recently reported at $1.2M.
Interactive year-over-year charts and full filing details available with membership.